{"id":"W2136112505","doi":"10.1016/j.leukres.2008.06.028","title":"In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":354,"is_retracted":false,"has_abstract":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; In vivo; Pharmacology; Drug; Therapeutic index; Medicine; Chemistry; Leukemia; Immunology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002903501,0.0004636353,0.0004017724,0.0002654547,0.0001896509,0.0003498503,0.0002480191,0.0003265183,0.001544123],"category_scores_gemma":[0.0001994351,0.0001736731,0.0001824901,0.0001763132,0.0002685727,0.0003839122,0.0001607646,0.0007489563,0.000291833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003624164,"about_ca_system_score_gemma":0.0003509205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000477137,"about_ca_topic_score_gemma":0.0005894192,"domain_scores_codex":[0.9997942,0.00004002535,0.00001560447,0.00004730084,0.00004089918,0.00006203648],"domain_scores_gemma":[0.9998631,0.00003299406,0.00003282715,0.00002041942,0.00001409424,0.00003661875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005523254,0.0001088391,0.00006141022,0.00001586622,0.000006522268,0.00001512546,0.00001316429,0.0001252551,0.996935,0.0001167764,0.00008079925,0.001968965],"study_design_scores_gemma":[0.00002621438,0.0004640479,0.0002324629,0.000001017456,0.00001386522,0.00006025959,0.000004530456,0.0005193815,0.9981151,0.00002285585,0.0005383103,0.000002002844],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918343,0.001375725,0.004682417,0.0001339057,0.00005686034,0.00005716416,0.0002036088,0.0002071071,0.001448957],"genre_scores_gemma":[0.9966463,0.0002539662,0.001829328,0.00001931368,0.00001415695,0.00003060128,0.0001065339,0.00003223544,0.001067537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001544123,"threshold_uncertainty_score":0.005165577,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05281627163083522,"score_gpt":0.32778969499979,"score_spread":0.2749734233689548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}